Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. However, the durability of protection is not known, nor is the effectiveness against emerging viral variants. Additionally, vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: McDade, Thomas W., Demonbreun, Alexis R., Sancilio, Amelia, Mustanski, Brian, D’Aquila, Richard T., McNally, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405730/
https://www.ncbi.nlm.nih.gov/pubmed/34462501
http://dx.doi.org/10.1038/s41598-021-96879-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405730/
https://www.ncbi.nlm.nih.gov/pubmed/34462501
http://dx.doi.org/10.1038/s41598-021-96879-3

Ejemplares similares